Chinese startup DeepSeek has debuted an AI app that challenges OpenAI's ChatGPT and other U.S. rivals, sending a shock ...

Fintel reports that on February 3, 2025, Wedbush upgraded their outlook for Tempur Sealy International (NYSE:TPX) from ...

Wedbush has a “Neutral” rating and a $104.00 price target on the stock. The consensus estimate for Alexandria Real Estate Equities’ current full-year earnings is $9.34 per share.

Wedbush analyst David Nierengarten maintained a Buy rating on AnaptysBio (ANAB – Research Report) today and set a price target of $40.00. The ...

Wedbush analyst Nick Setyan raised the firm’s price target on Dutch Bros (BROS) to $80 from $65 and keeps an Outperform rating on the shares.

Wedbush currently has a “Outperform” rating and a $34.00 target price on the stock. The consensus estimate for Kiniksa Pharmaceuticals’ current full-year earnings is ($0.55) per share.

Fintel reports that on February 6, 2025, Wedbush initiated coverage of Bicara Therapeutics (NasdaqGM:BCAX) with a Outperform ...

Here’s what you need to know about DeepSeek, the Chinese AI startup that rattled markets as its app dethroned OpenAI's as the ...